Plus   Neg

Cirrus Logic Cuts Q3 Revenue Outlook, Shares Slip 6%

Shares of Cirrus Logic Inc. (CRUS) slipped 6% on Monday's extended session after the company lowered its revenue outlook for the third quarter due to "recent weaknesses in the smartphone market."

The company now expects third-quarter revenues of $300 million and $340 million, down from previous forecast of $360 million and $400 million. Analysts polled by Thomson Reuters expected revenues of $368.34 million.

The company expects gross margin is expected to be between 49 and 51% and combined R&D and SG&A expenses are expected to range between $118 million and $124 million.

CRUS closed Monday's trading at $38.67, up $1.23 or 3.29%, on the Nasdaq. The stock, however, slipped $2.32 or 6.00% in the after-hours trade.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020. Walmart announced its decision to raise wages for around 165,000 hourly associates across all its U.S. stores starting October, and introduce a team-based operating model in Supercenters. In a tweet, the retail giant said, "Today we're introducing new leadership roles and cross-training opportunities, giving our associates more ways to grow their careers."
Follow RTT